Patel Anish

Chief Operating Officer | Chief Operating Officer

1 company

Average

Trades Analyzed

12M Win Rate

41.7%

Avg 3M Return

-12.0%

Avg 12M Return

-24.0%

Patel Anish is a Chief Operating Officer at Enliven Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 20 sells.

Estimated insider holdings value: $9.7M based on current market prices.

Holdings by Company

ELVNJan 9, 2026

Current Shares215.0K

Value$9.70M

Net Activity-259,716

Bought: 0Sold: 259.7K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 9, 2026	ELVN Enliven Therapeutics, Inc.	Chief Operating Officer	Sell	48,300	$27.99	$1,351,762.20	-10.1%	+75.3%	-
Dec 8, 2025	ELVN Enliven Therapeutics, Inc.	Chief Operating Officer	Sell	6,663	$21.02	$140,072.86	-1.2%	+45.1%	-
Nov 7, 2025	ELVN Enliven Therapeutics, Inc.	Chief Operating Officer	Sell	6,667	$17.40	$116,034.16	-1.2%	+53.1%	-
Oct 7, 2025	ELVN Enliven Therapeutics, Inc.	Chief Operating Officer	Sell	6,667	$20.10	$133,992.70	-2.4%	-24.4%	-
Sep 8, 2025	ELVN Enliven Therapeutics, Inc.	Chief Operating Officer	Sell	6,667	$20.24	$134,957.41	-2.3%	+2.5%	-
Aug 7, 2025	ELVN Enliven Therapeutics, Inc.	Chief Operating Officer	Sell	6,667	$18.24	$121,615.52	-1.1%	+3.4%	-
Jul 7, 2025	ELVN Enliven Therapeutics, Inc.	Chief Operating Officer	Sell	6,667	$19.79	$131,950.60	-1.1%	+3.6%	-
Jun 9, 2025	ELVN Enliven Therapeutics, Inc.	Chief Operating Officer	Sell	6,667	$20.34	$135,574.05	-1.1%	-1.6%	+77.5%
May 7, 2025	ELVN Enliven Therapeutics, Inc.	Chief Operating Officer	Sell	6,667	$18.39	$122,578.86	-0.7%	+5.2%	+120.5%
Apr 7, 2025	ELVN Enliven Therapeutics, Inc.	Chief Operating Officer	Sell	6,667	$18.04	$120,268.73	-0.7%	+9.6%	+141.5%